What Is Non-Hodgkin Lymphoma/NHL?

Dr. Rosen introduces himself and describes non-Hodgkin lymphoma (NHL).

Dr. Rosen:
I am Steve Rosen. I am the Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and also the Director of cancer programs at Northwestern Memorial Hospital. I am a medical oncologist and hematologist. My major focus is the treatment of blood cancers, which include leukemias, lymphomas, and multiple myeloma, and I also take care of a large number of women with breast cancer.

So, non-Hodgkin’s lymphoma is one of the blood cancers; it’s actually the most common blood cancer. Approximately 60,000 individuals will be diagnosed with a non-Hodgkin’s lymphoma this year in the United States. It’s a disease that typically arises in lymph nodes; those are the glands of the body. It can also involve the spleen as a major site of initial involvement.

About Dr. Steven Rosen, M.D., F.A.C.P:
Steven Rosen, M.D., F.A.C.P., is Genevieve Teuton Professor of Medicine, at the Feinberg School of Medicine, Northwestern University and Director of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Director of Cancer Programs at Northwestern Memorial Hospital. Following his graduation with distinction from Northwestern University Medical School's Six-Year Honors Program in 1976, Dr. Rosen completed his residency in Internal Medicine at Northwestern and a fellowship in Medical Oncology at the National Cancer Institute. Dr. Rosen's laboratory research focuses on experimental therapeutics and hematologic malignancies.

Visit Dr. Rosen at Northwestern Memorial Hospital